Search

everythinglearnresearchcommunity

for

Search:↓

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Women with PCOS have higher irisin levels, which may affect their metabolism and hormones.

Anagen grow may effectively treat hair loss by blocking testosterone and reducing enzyme activity.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Higher sebum levels are linked to more severe male baldness.

Women with certain types of hair loss may have low iron levels.

Neurosteroids like neuro-estrogen and neuro-androgen are crucial for brain function and can improve cognition and protect against aging-related decline.

Adolescent females with PCOS have higher serum cystatin C levels, indicating potential metabolic and cardiovascular issues.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

Alopecia patients have less GPER-1, which might affect hair loss.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

The balance between androgen receptor and p53 is crucial for sebaceous gland differentiation.

Testosterone conversion to 5α-DHT may not be essential for its effects on the skin.

Low zinc and biotin levels linked to male hair loss; supplements may help.

Anti-androgens are effective for female acne but less so for male-pattern hair loss, with side effects similar to birth control pills.

Higher apelin-12 levels may indicate more severe acne.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.

Women with a certain type of tumor had higher levels of pregnancy hormone and male hormones, which decreased after treatment.

The method accurately measures steroid hormones in hair to study hormone dynamics related to hair loss.

Cells from balding scalps have more androgen receptors than cells from non-balding scalps.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Androgens can cause hair growth in some areas and hair loss on the scalp.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.